{"meta":{"query_hash":"13fea598a257","filters":{"venue":"Drug development & registration"},"cohort_total":29,"direct_labels_cover":0,"predictions_cover":29,"exported":29,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/13fea598a257","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+development+%26+registration"},"results":[{"id":"W2911230576","doi":"10.33380/2305-2066-2019-8-1-113-117","title":"CERTIFICATION OF QUALITY MANAGEMENT SYSTEM OF LLC «CENTER OF PHARMACEUTICAL ANALYTICS» ACCORDING TO THE REQUIREMENTS OF ISO 9001:2015 (GOST R ISO 9001-2015) (REVIEW)","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Economic, Social, and Public Health Issues in Russia and Globally","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Certification; Quality management system; Audit; Accreditation; Quality audit; Certificate; Quality assurance; Business; Management system; Conformity assessment; Quality management; Engineering management; Accounting; Computer science; Operations management; Engineering; Medicine; Service (business); Management","score_opus":0.1793563772042008,"score_gpt":0.46201145828794593,"score_spread":0.28265508108374515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911230576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8915057,0.002716167,0.010014972,0.018482966,0.0024801914,0.004398695,0.0001530133,0.000043022163,0.07020524],"genre_scores_gemma":[0.9961123,0.0004999728,0.0017119223,0.0003171202,0.000039167582,0.0000270363,0.000051692026,0.0000079350675,0.001232875],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99468094,0.00041922586,0.0028830832,0.00043287245,0.0013269839,0.00025689663],"domain_scores_gemma":[0.9963177,0.00023385207,0.0019147164,0.00075445883,0.00066324166,0.00011604094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00975848,0.00017201758,0.000653468,0.00017729597,0.00008733553,0.000036561833,0.0008122183,0.00007386936,0.00013925339],"category_scores_gemma":[0.00032385532,0.00012706425,0.00013432985,0.00058911694,0.00009471746,0.0002544952,0.00014377336,0.00008449294,0.000080166865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009952557,0.0019291785,0.37144282,0.02128571,0.00097086164,0.0000029513592,0.018831518,0.0007307394,0.0032993965,0.18589297,0.19641414,0.19820444],"study_design_scores_gemma":[0.0030453326,0.0002376632,0.26305103,0.0047872793,0.0002526328,0.0000042380584,0.029745908,0.002419508,0.014336401,0.0012587636,0.67994255,0.00091871276],"about_ca_topic_score_codex":0.00009542772,"about_ca_topic_score_gemma":0.0000642763,"teacher_disagreement_score":0.48352838,"about_ca_system_score_codex":0.00020552626,"about_ca_system_score_gemma":0.00030661764,"threshold_uncertainty_score":0.51815295},"labels":[],"label_agreement":null},{"id":"W2947580881","doi":"10.33380/2305-2066-2019-8-2-108-114","title":"Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Tadalafil; Protein precipitation; Chromatography; Calibration curve; Chemistry; Pharmacokinetics; High-performance liquid chromatography; Detection limit; Quantitative analysis (chemistry); Extraction (chemistry); Matrix (chemical analysis); Bioequivalence; Analyte; Erectile dysfunction; Pharmacology; Medicine","score_opus":0.04108518812559655,"score_gpt":0.35733628049779986,"score_spread":0.31625109237220334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947580881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227154,0.000026763568,0.0032856227,0.0002445659,0.000044448097,0.00041506172,0.0000014234361,0.000024794545,0.003685797],"genre_scores_gemma":[0.9628983,0.000006360616,0.0353239,0.000089413086,0.00001460224,0.000029349048,0.00024509395,0.000010361153,0.0013825871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985322,0.00007766348,0.00060922303,0.0002620659,0.00035663502,0.00016224131],"domain_scores_gemma":[0.9994651,0.000059609185,0.00021198552,0.00010427664,0.00009533541,0.000063700565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011106081,0.00013087173,0.00022402414,0.00012054206,0.0000610528,0.000025399393,0.000050705446,0.000074416654,0.00005011321],"category_scores_gemma":[0.000056447603,0.00013330873,0.000016752032,0.00016911676,0.000024807843,0.00020490057,0.000023624658,0.00012848189,0.000010130934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022281095,0.00043697885,0.041291915,0.0011388436,0.000052177893,0.000008201489,0.012736037,0.000019925435,0.7574482,0.002583818,0.00026819287,0.1837929],"study_design_scores_gemma":[0.001524245,0.000029691719,0.024880325,0.00028261502,0.000017790204,0.000012073606,0.0005267402,0.0018617257,0.9572994,0.00007388336,0.013299263,0.00019223634],"about_ca_topic_score_codex":0.00002388187,"about_ca_topic_score_gemma":0.00003538124,"teacher_disagreement_score":0.19985121,"about_ca_system_score_codex":0.00016223938,"about_ca_system_score_gemma":0.0001878575,"threshold_uncertainty_score":0.5436172},"labels":[],"label_agreement":null},{"id":"W2971404000","doi":"10.33380//2305-2066-2019-8-3-91-100","title":"A Comparative Parallel Study of Pharmacokinetics and Immunogenicity Following Single Intravenous Administration of Bevacizumab Biosimilar RPH-001 (Manufactured by R-Pharm Group, Russia) and Avastin® (Manufactured by F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Male Volunteers","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Bevacizumab; Medicine; Pharmacokinetics; Immunogenicity; Biosimilar; Pharmacology; Antibody; Internal medicine; Immunology; Chemotherapy","score_opus":0.015063345169092792,"score_gpt":0.27465102252259677,"score_spread":0.25958767735350396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971404000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949386,0.0029254379,0.00037915658,0.0002843287,0.00016865063,0.0010699253,0.00005783808,0.00002016254,0.00015587357],"genre_scores_gemma":[0.9974439,0.00018539622,0.0014586548,0.00009591951,0.0000069674725,0.000027286935,0.00046205684,0.000015171595,0.00030461923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976318,0.0004361753,0.00091535965,0.00052903855,0.0001525774,0.00033505313],"domain_scores_gemma":[0.9990533,0.00016986085,0.0004651214,0.00019730703,0.00005711127,0.000057292582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071163685,0.00034009438,0.000714556,0.0001277429,0.00010698008,0.000034749475,0.00016146741,0.00026705736,0.000053114934],"category_scores_gemma":[0.000028595505,0.00030572392,0.000057003344,0.00014789228,0.00016799352,0.00013475645,0.00006320216,0.00033850333,0.0000023713114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045105107,0.004025992,0.0071712607,0.0002586308,0.0008196025,0.000012175037,0.01017181,0.000015760748,0.9640881,0.000023642899,0.0021391534,0.006763393],"study_design_scores_gemma":[0.017667389,0.0039099287,0.043343496,0.0001758681,0.00038664218,0.000066519264,0.005127229,0.00020906825,0.91680664,0.00006719563,0.011334606,0.00090539776],"about_ca_topic_score_codex":0.00014844007,"about_ca_topic_score_gemma":0.00025765487,"teacher_disagreement_score":0.047281407,"about_ca_system_score_codex":0.00008604735,"about_ca_system_score_gemma":0.000097996744,"threshold_uncertainty_score":0.9999395},"labels":[],"label_agreement":null},{"id":"W2972024183","doi":"10.33380/2305-2066-2019-8-3-79-84","title":"Development and Validation of HPLC-MS/MS Method for Busereline Quantitation in Animal Blood Plasma","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Protein precipitation; Chromatography; High-performance liquid chromatography; Chemistry; Sample preparation; Pharmacokinetics; Extraction (chemistry); Pharmacology; Medicine","score_opus":0.03168130250184206,"score_gpt":0.3088721256624127,"score_spread":0.27719082316057064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972024183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943742,0.00013800505,0.0030561269,0.00062899466,0.000077758494,0.0009135673,0.000002059533,0.000021195445,0.00078805594],"genre_scores_gemma":[0.79059166,0.000032317337,0.20804311,0.000015659427,0.000042549655,0.00006726993,0.0001768746,0.000010929466,0.0010196518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866706,0.000031001084,0.00054350507,0.00034809444,0.0002633196,0.00014702631],"domain_scores_gemma":[0.99934554,0.00006305916,0.00020935327,0.00010608198,0.00023992355,0.000036065492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008193747,0.0001438949,0.0002932718,0.00015190158,0.000063027124,0.000011760733,0.00003510345,0.00005665534,0.000008245292],"category_scores_gemma":[0.00012623395,0.00012262094,0.000027288652,0.00016932671,0.000026541771,0.00012601135,0.000021956956,0.00006975673,0.000006399548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003291666,0.0015796092,0.20775726,0.0031509385,0.00065456884,0.000014471086,0.042370453,0.00020587855,0.6418923,0.016171228,0.00050296326,0.08240862],"study_design_scores_gemma":[0.0028266378,0.00023261493,0.3926666,0.00021350123,0.0000689716,0.000015705114,0.0016662852,0.0006391262,0.5909126,0.0001360129,0.010381131,0.00024082979],"about_ca_topic_score_codex":0.000032767693,"about_ca_topic_score_gemma":0.00012616038,"teacher_disagreement_score":0.20498699,"about_ca_system_score_codex":0.000061908664,"about_ca_system_score_gemma":0.00024203438,"threshold_uncertainty_score":0.5000337},"labels":[],"label_agreement":null},{"id":"W2989685308","doi":"10.33380/2305-2066-2019-8-4-61-74","title":"Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmacological Effects and Assays","field":"Agricultural and Biological Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Ambroxol; Chromatography; Chemistry; Salbutamol; Pharmacokinetics; Bioequivalence; High-performance liquid chromatography; Solid phase extraction; Pharmacology; Medicine; Anesthesia; Asthma","score_opus":0.016696855331731028,"score_gpt":0.26685921259953127,"score_spread":0.25016235726780023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989685308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983899,0.0000346142,0.00012317664,0.00020269345,0.000041287352,0.00044579967,0.000004420236,0.000025280584,0.0007328105],"genre_scores_gemma":[0.9909,0.000015894555,0.008245755,0.000045842175,0.000020200054,0.00003719675,0.00024596142,0.0000014937315,0.00048765118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987073,0.000121930985,0.00041894536,0.00033759052,0.00023540587,0.00017882642],"domain_scores_gemma":[0.9995084,0.00012989294,0.00021948585,0.000034082314,0.000045630048,0.00006255536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007197597,0.0001602836,0.00020854681,0.000031330666,0.00012021831,0.000061472965,0.00009053568,0.000090611735,0.00006596018],"category_scores_gemma":[0.00002515138,0.00008091,0.00001722592,0.00017686837,0.000032193744,0.00023093609,0.000048660197,0.000082068975,0.0000040380564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020439837,0.00008038723,0.010061468,0.000039786108,0.0000048063866,0.0000010911463,0.00032614576,0.000005364501,0.8692504,0.00016091963,0.00009856744,0.11995058],"study_design_scores_gemma":[0.0005196367,0.000077186276,0.3238582,0.00006587232,0.0000069118855,0.000004266563,0.0001387016,0.0007323817,0.6652099,0.00012345724,0.008998608,0.00026492053],"about_ca_topic_score_codex":0.000106254825,"about_ca_topic_score_gemma":0.00023703328,"teacher_disagreement_score":0.31379673,"about_ca_system_score_codex":0.0000558069,"about_ca_system_score_gemma":0.000023017246,"threshold_uncertainty_score":0.3299414},"labels":[],"label_agreement":null},{"id":"W2991632468","doi":"10.33380/2305-2066-2019-8-4-53-60","title":"Chemical and Toxicological Analysis of Antiretroviral Drugs","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Efavirenz; Nevirapine; Atazanavir; Ritonavir; Darunavir; Abacavir; Zidovudine; Medicine; Pharmacology; Lamivudine; Lopinavir; Urine; Human immunodeficiency virus (HIV); Virology; Internal medicine; Viral load; Antiretroviral therapy; Viral disease; Virus","score_opus":0.009202233969733001,"score_gpt":0.24868486596939834,"score_spread":0.23948263199966535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991632468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228483,0.00007079627,0.00006337654,0.00080939045,0.000045551096,0.00036463476,0.0000027738204,0.000044434546,0.0063142236],"genre_scores_gemma":[0.9794514,0.00002618212,0.0069054128,0.000084189254,0.00001656749,0.000018503142,0.00036065708,0.0000090352,0.013128046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985752,0.00002504623,0.00045390107,0.00035234055,0.00039433644,0.0001991538],"domain_scores_gemma":[0.9994219,0.00004226603,0.0001567922,0.00019410923,0.000079115234,0.00010582414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026300154,0.00017771014,0.00047717313,0.00026819584,0.000041313608,0.00001985897,0.00005854446,0.000093502975,0.00020848485],"category_scores_gemma":[0.000027978944,0.00014374695,0.00009841547,0.00054095656,0.000067093446,0.00008882717,0.00003952821,0.00009542337,0.000043737622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003176126,0.00061608804,0.9285381,0.00017269226,0.0016884255,0.000027472297,0.0044394326,0.000006334668,0.040719636,0.0019664553,0.0014555968,0.020052172],"study_design_scores_gemma":[0.004574085,0.00020621745,0.78623474,0.0001787414,0.002075029,0.000025696123,0.0014952782,0.0015308207,0.18498671,0.00006929317,0.017908001,0.00071538816],"about_ca_topic_score_codex":0.0000061766045,"about_ca_topic_score_gemma":0.0000068780473,"teacher_disagreement_score":0.14426708,"about_ca_system_score_codex":0.00011851273,"about_ca_system_score_gemma":0.00019114687,"threshold_uncertainty_score":0.586183},"labels":[],"label_agreement":null},{"id":"W3008140779","doi":"10.33380/2305-2066-2020-9-1-99-108","title":"Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Atazanavir; Ritonavir; Pharmacokinetics; Chromatography; Human plasma; Protein precipitation; Therapeutic drug monitoring; Chemistry; Pharmacology; Human immunodeficiency virus (HIV); Medicine; Antiretroviral therapy; Viral load; Virology","score_opus":0.025053923488284408,"score_gpt":0.2949525593858599,"score_spread":0.2698986358975755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008140779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939315,0.000112990805,0.0020191679,0.0020879593,0.000026608468,0.00069410336,0.0000046832124,0.00005047744,0.0010725164],"genre_scores_gemma":[0.8525229,0.000044555138,0.14458291,0.00008972931,0.000025178668,0.000093782386,0.0008431543,0.000024388728,0.0017733861],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800164,0.0000720702,0.00078653096,0.0004894737,0.0004306177,0.00021966256],"domain_scores_gemma":[0.99930733,0.00004937598,0.0002704466,0.000118655546,0.000082916435,0.00017128358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005072601,0.00026874698,0.00039032067,0.00017529713,0.0001387458,0.00004235903,0.00006364912,0.000106268984,0.00001993275],"category_scores_gemma":[0.00005274869,0.0002625684,0.000025499307,0.0002659009,0.000055514185,0.00025017277,0.000053730117,0.00013574988,0.000006582391],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056866044,0.0010772136,0.17952691,0.0016841821,0.0003178796,0.000117328724,0.07369046,0.000016188449,0.26729667,0.0016110723,0.0035941987,0.47049922],"study_design_scores_gemma":[0.0035191183,0.00007629236,0.054749645,0.00032571433,0.000081370104,0.000029313866,0.0010065471,0.0011462553,0.8995891,0.000059418857,0.038923245,0.00049396616],"about_ca_topic_score_codex":0.000024449184,"about_ca_topic_score_gemma":0.00007637305,"teacher_disagreement_score":0.63229245,"about_ca_system_score_codex":0.00017067375,"about_ca_system_score_gemma":0.00024811018,"threshold_uncertainty_score":0.99998266},"labels":[],"label_agreement":null},{"id":"W3030930859","doi":"10.33380/2305-2066-2020-9-2-140-144","title":"Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Immunogenicity; Neutropenia; Immunoassay; Internal medicine; Breast cancer; Cancer; Oncology; Antibody; Immunology; Chemotherapy","score_opus":0.011224525604323868,"score_gpt":0.265162422345945,"score_spread":0.25393789674162115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030930859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995851,0.000016653285,0.00039626498,0.0017090527,0.000047802474,0.00042419977,0.000013488762,0.000022563268,0.001518992],"genre_scores_gemma":[0.9981278,0.000011858109,0.0013527722,0.00020482266,0.000028817582,0.000062146566,0.0000975051,0.000009891594,0.00010435809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991206,0.00001769828,0.0002769337,0.00018334121,0.0002876406,0.00011381487],"domain_scores_gemma":[0.9995534,0.000005409912,0.00012997969,0.0000971902,0.00014797618,0.00006605719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062723164,0.000101186924,0.00017989724,0.000045509354,0.000041510688,0.000009944837,0.000043977223,0.000025997242,0.00013660586],"category_scores_gemma":[0.000004255269,0.00008301756,0.000023722538,0.0002594193,0.000029244538,0.00009769516,0.000013694229,0.000112065405,0.0000032675619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028214013,0.00021400012,0.9928151,0.00007892283,0.00004074686,0.0000023328419,0.00044172836,0.00009781643,0.0011631385,0.00007224776,0.00035391602,0.0044379625],"study_design_scores_gemma":[0.0019063348,0.000084420186,0.9944491,0.00010535137,0.000029189396,0.0000020287455,0.00005885475,0.000051469433,0.0020952786,0.0000017209303,0.0011237359,0.0000925362],"about_ca_topic_score_codex":0.00014659991,"about_ca_topic_score_gemma":0.00024228224,"teacher_disagreement_score":0.0043454263,"about_ca_system_score_codex":0.00019561365,"about_ca_system_score_gemma":0.0006361099,"threshold_uncertainty_score":0.3385358},"labels":[],"label_agreement":null},{"id":"W3031640402","doi":"10.33380/2305-2066-2020-9-2-145-150","title":"Method of Estimating the Equivalence of Dissolution Profiles: a Modern View (Review)","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Mahalanobis distance; Outlier; Similarity (geometry); Equivalence (formal languages); Dissolution; Statistics; Mathematics; Weibull distribution; Comparability; Dissolution testing; Sample (material); Computer science; Econometrics; Combinatorics; Chemistry; Chromatography; Artificial intelligence; Discrete mathematics","score_opus":0.16604727660008556,"score_gpt":0.4344404072342946,"score_spread":0.26839313063420905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031640402","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12407283,0.04255529,0.79306185,0.021313077,0.0014796767,0.0053333687,0.00010919526,0.00026216183,0.011812525],"genre_scores_gemma":[0.9571564,0.0011976992,0.039265245,0.0017570459,0.00011818457,0.00012275857,0.000083350475,0.0000140290185,0.00028525625],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978196,0.00061729766,0.0008353797,0.00024485608,0.00029562454,0.00018723313],"domain_scores_gemma":[0.9987193,0.00021303807,0.00064973265,0.00016083714,0.00017409585,0.0000830211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019818959,0.00015529951,0.0003318133,0.000023573926,0.00015024864,0.0000070227343,0.0002803765,0.000088866436,0.000102628714],"category_scores_gemma":[0.00020130583,0.0001207479,0.00007905086,0.0002489872,0.000117295385,0.00014066446,0.00006073233,0.00025467167,0.000024356264],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051404675,0.0007336353,0.0038783166,0.029793087,0.0005501575,0.0000141898445,0.057042003,0.018944364,0.09230449,0.0069935573,0.04672973,0.7425024],"study_design_scores_gemma":[0.0018382493,0.00020529894,0.0029190884,0.0040986626,0.0006382078,0.000046724108,0.0015319941,0.6085553,0.18040015,0.00087265595,0.19796976,0.00092392747],"about_ca_topic_score_codex":0.000017835457,"about_ca_topic_score_gemma":0.000009175635,"teacher_disagreement_score":0.8330836,"about_ca_system_score_codex":0.00003763391,"about_ca_system_score_gemma":0.0002402506,"threshold_uncertainty_score":0.49239564},"labels":[],"label_agreement":null},{"id":"W3109322209","doi":"10.33380/2305-2066-2020-9-4-146-154","title":"Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pomalidomide; Protein precipitation; Chromatography; High-performance liquid chromatography; Detection limit; Multiple myeloma; Chemistry; Pharmacokinetics; Thalidomide; Pharmacology; Medicine; Internal medicine","score_opus":0.060066103925766626,"score_gpt":0.36677226588327055,"score_spread":0.30670616195750394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109322209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93364763,0.000040285406,0.057980623,0.0006100924,0.000030707066,0.0002166409,0.0000055097134,0.00006818825,0.0074003367],"genre_scores_gemma":[0.6111955,0.000009232339,0.38796508,0.00008874716,0.000037203157,0.00004771031,0.00016194725,0.000021942129,0.00047261323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976379,0.00013183393,0.0010207939,0.00048691226,0.00047132652,0.00025119938],"domain_scores_gemma":[0.9990135,0.0002117871,0.00037492596,0.00014873594,0.0000898165,0.00016127239],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010443883,0.00024137873,0.00033920375,0.00008621718,0.000107212996,0.000054195363,0.00018202391,0.00014544193,0.00021255309],"category_scores_gemma":[0.0004097673,0.00026070635,0.00003457301,0.00023206904,0.00007071283,0.00022542899,0.0000791463,0.0002200219,0.000007597683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010724629,0.0001695594,0.0046792817,0.00061783806,0.000050722734,0.0000102556105,0.005612371,0.000047372494,0.8746197,0.0019145808,0.00041384905,0.11175723],"study_design_scores_gemma":[0.00082240393,0.000007424422,0.000713677,0.0000858858,0.000025051813,0.0000036337997,0.00024725628,0.004996512,0.97928166,0.00027000357,0.013258783,0.00028773054],"about_ca_topic_score_codex":0.000013859582,"about_ca_topic_score_gemma":0.000014140202,"teacher_disagreement_score":0.32998446,"about_ca_system_score_codex":0.00019831068,"about_ca_system_score_gemma":0.00015490025,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W3129249197","doi":"10.33380/2305-2066-2021-10-1-120-128","title":"Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Valganciclovir; Ganciclovir; Chromatography; High-performance liquid chromatography; Protein precipitation; Chemistry; Pharmacokinetics; Detection limit; Active metabolite; Metabolite; Human cytomegalovirus; Pharmacology; Medicine; Biochemistry","score_opus":0.032049846437376066,"score_gpt":0.33493987102995376,"score_spread":0.3028900245925777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129249197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958946,0.00064586615,0.0010555419,0.00027732135,0.00003756133,0.0005572689,0.000011256027,0.000025748079,0.0014947974],"genre_scores_gemma":[0.9611082,0.00022687828,0.03579998,0.00005695592,0.000034699584,0.00009069099,0.0004955478,0.000026842827,0.002160224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772894,0.00015190407,0.000712119,0.00051374524,0.0006037351,0.00028956935],"domain_scores_gemma":[0.99903995,0.00007468981,0.0002481155,0.00016625885,0.0003231999,0.00014776533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010282688,0.0002298929,0.00042179492,0.00028078211,0.00016492467,0.00006596064,0.0000624441,0.00013409118,0.000055032408],"category_scores_gemma":[0.00016034667,0.00023462683,0.00003245867,0.00041719113,0.000047132347,0.00034741595,0.00007262292,0.0002277354,0.000005615509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019723644,0.00032993982,0.0044622123,0.00049417454,0.000084110085,0.000040791063,0.009408718,0.0000043178925,0.79916847,0.0010205578,0.00018014481,0.18460934],"study_design_scores_gemma":[0.0015562885,0.00002604834,0.077478886,0.00013038529,0.00003201855,0.00003493397,0.00043062487,0.00054625253,0.8995663,0.000058835212,0.019920386,0.00021905296],"about_ca_topic_score_codex":0.00006807717,"about_ca_topic_score_gemma":0.00032802223,"teacher_disagreement_score":0.18439029,"about_ca_system_score_codex":0.0002549747,"about_ca_system_score_gemma":0.0006589162,"threshold_uncertainty_score":0.95678043},"labels":[],"label_agreement":null},{"id":"W3130804109","doi":"10.33380/2305-2066-2021-10-1-83-89","title":"Isolation of Individual Compounds from the Terrestrial Parts of Ononis Arvensis L. and Solidago Canadensis L.","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Medicinal plant effects and applications","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Saint petersburg; Traditional medicine; Botany; Solidago canadensis; Biology; Isolation (microbiology); Chemistry; Invasive species","score_opus":0.027100276456940214,"score_gpt":0.26260469248008633,"score_spread":0.23550441602314612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130804109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470824,0.00020320607,0.0008118296,0.0032651182,0.00009447801,0.00024104807,0.000032790416,0.000008364759,0.00063493894],"genre_scores_gemma":[0.9953917,0.000044027707,0.003152564,0.00016571855,0.00010921202,0.000012056553,0.0009517406,0.000005173011,0.00016776285],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990303,0.000048961356,0.00036128957,0.00015796194,0.0003165554,0.00008496362],"domain_scores_gemma":[0.99928766,0.00019062194,0.00021203785,0.00016693809,0.00008880786,0.000053932697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027142136,0.00008417631,0.0002052561,0.000029629104,0.00008352651,0.00001821908,0.000044721888,0.00004542976,0.000022459102],"category_scores_gemma":[0.00010053792,0.000063109896,0.000027001772,0.00012050895,0.00007394401,0.000039222105,0.00002032693,0.00008000702,0.0000010846435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010849839,0.0011770809,0.29963198,0.00072426005,0.0014857752,0.00011231298,0.0367521,0.000080849924,0.36935776,0.0053315647,0.13723746,0.14702389],"study_design_scores_gemma":[0.001987879,0.000086738386,0.8393239,0.00051512104,0.00038830156,0.00005368739,0.0022413,0.0005100542,0.127261,0.0002533455,0.027188756,0.00018994245],"about_ca_topic_score_codex":0.0008566098,"about_ca_topic_score_gemma":0.0020205802,"teacher_disagreement_score":0.5396919,"about_ca_system_score_codex":0.00002398427,"about_ca_system_score_gemma":0.00045782383,"threshold_uncertainty_score":0.25735468},"labels":[],"label_agreement":null},{"id":"W3132138449","doi":"10.33380/2305-2066-2021-10-1-31-36","title":"PD-L1 as a Potential Target in Cancer Therapy (Review)","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Durvalumab; Avelumab; Immunotherapy; Immune system; Cancer; Medicine; Clinical trial; Cancer immunotherapy; Mechanism (biology); Immunology; Cancer research; Internal medicine; Nivolumab","score_opus":0.019832939404268567,"score_gpt":0.3036877309930628,"score_spread":0.28385479158879423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132138449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7816477,0.18208948,0.00025995143,0.024324944,0.00072887604,0.0010972931,0.000006160654,0.000084171064,0.0097614685],"genre_scores_gemma":[0.73557276,0.20771876,0.0053675547,0.016097493,0.00033417338,0.00045924782,0.0008263163,0.00005083395,0.03357284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987768,0.00004938645,0.00039049427,0.00027388183,0.00032152946,0.00018788682],"domain_scores_gemma":[0.999536,0.0000075598514,0.00010766199,0.00018494674,0.00011175584,0.000052092328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029726405,0.00014127338,0.00022602222,0.00005629263,0.000056852234,0.000019422087,0.0000562629,0.000055613404,0.0014365544],"category_scores_gemma":[0.000021260304,0.00012590375,0.00007363578,0.00030493503,0.000029122555,0.00008511135,0.000011057588,0.00011545435,0.000029245062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032889997,0.0012167778,0.017552035,0.0013463089,0.0004629778,0.00079064624,0.0034640324,0.00002430593,0.17282186,0.00017590878,0.12627515,0.67258096],"study_design_scores_gemma":[0.003581141,0.00005538833,0.13441132,0.0016924441,0.000025558104,0.00010424338,0.00024213361,0.000031264677,0.09127207,0.00006492469,0.76820487,0.0003146373],"about_ca_topic_score_codex":0.00021960039,"about_ca_topic_score_gemma":0.00036896605,"teacher_disagreement_score":0.67226636,"about_ca_system_score_codex":0.00023327286,"about_ca_system_score_gemma":0.0013728495,"threshold_uncertainty_score":0.99947625},"labels":[],"label_agreement":null},{"id":"W3169402917","doi":"10.33380/2305-2066-2021-10-2-120-127","title":"Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Tranexamic acid; Chromatography; High-performance liquid chromatography; Protein precipitation; Pharmacokinetics; Chemistry; Calibration curve; Bioequivalence; Selected reaction monitoring; Tandem mass spectrometry; Detection limit; Mass spectrometry; Pharmacology; Medicine; Blood loss; Surgery","score_opus":0.020985831172852215,"score_gpt":0.28695898020178245,"score_spread":0.2659731490289302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169402917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760696,0.00008489143,0.018657688,0.0006571853,0.00006588968,0.00054852816,0.0000017185605,0.000037971764,0.003876506],"genre_scores_gemma":[0.88397735,0.000062257386,0.11291231,0.00010105483,0.000014075022,0.000071376715,0.00063661963,0.000016188755,0.0022087893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983309,0.000082398816,0.00065627036,0.00036055644,0.00039995907,0.00016992136],"domain_scores_gemma":[0.9994808,0.000022746412,0.00016160442,0.00015555248,0.00010772133,0.00007156534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006501202,0.00016976909,0.00026981733,0.00018220893,0.00009319165,0.00003069163,0.000051040297,0.000085755004,0.00007351635],"category_scores_gemma":[0.000029061275,0.00017767944,0.000029182129,0.00025221074,0.000026640057,0.00014556828,0.000022067823,0.00011492611,0.00000362427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009011718,0.0006837206,0.0030960196,0.00073554064,0.00007709054,0.000047060515,0.01012222,0.0000104391775,0.7224986,0.0012906386,0.00054303097,0.26080555],"study_design_scores_gemma":[0.0021316917,0.000025690768,0.029517788,0.00019843486,0.00004678643,0.000023688981,0.0005532758,0.00021969981,0.9472666,0.000040687508,0.019790994,0.00018465528],"about_ca_topic_score_codex":0.00003033023,"about_ca_topic_score_gemma":0.00041709986,"teacher_disagreement_score":0.2606209,"about_ca_system_score_codex":0.00012863218,"about_ca_system_score_gemma":0.00024604955,"threshold_uncertainty_score":0.72455573},"labels":[],"label_agreement":null},{"id":"W3172267348","doi":"10.33380/2305-2066-2021-10-2-87-99","title":"HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Cholecalciferol; Vitamin D and neurology; Vitamin; Chromatography; High-performance liquid chromatography; Chemistry; Extraction (chemistry); Medicine; Biochemistry; Internal medicine","score_opus":0.04060706993902249,"score_gpt":0.34464147568001974,"score_spread":0.30403440574099727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172267348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98254913,0.0007152428,0.011747693,0.0028547335,0.00014868648,0.0015877485,0.00001498943,0.000080421276,0.00030134938],"genre_scores_gemma":[0.82655674,0.0007308739,0.1688288,0.00017664696,0.00008054107,0.0006689511,0.0016428219,0.00005616105,0.001258435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966714,0.00021608433,0.00092436053,0.000824765,0.0008405672,0.00052285107],"domain_scores_gemma":[0.99857324,0.00026832454,0.0002366401,0.000259341,0.0004721203,0.00019035683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002039387,0.00036158235,0.00050187384,0.00035858568,0.0003756941,0.00013249196,0.000076404314,0.00013814137,0.000012381499],"category_scores_gemma":[0.0005951979,0.0003614769,0.000052253934,0.0004352721,0.000105442436,0.00040113073,0.00014542186,0.00020361053,0.000011589904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085216935,0.0013067176,0.03892929,0.0036243643,0.00079868163,0.00020356593,0.04645023,0.00004771776,0.5203495,0.0025147256,0.013410962,0.37151206],"study_design_scores_gemma":[0.005535305,0.00016571625,0.4010459,0.0005963367,0.00011115011,0.000045966695,0.0031113967,0.0009794986,0.5577415,0.00030503207,0.029742759,0.0006193961],"about_ca_topic_score_codex":0.000012540386,"about_ca_topic_score_gemma":0.00044305014,"teacher_disagreement_score":0.37089264,"about_ca_system_score_codex":0.00042034942,"about_ca_system_score_gemma":0.00072643056,"threshold_uncertainty_score":0.9998837},"labels":[],"label_agreement":null},{"id":"W3197910357","doi":"10.33380/2305-2066-2021-10-3-55-69","title":"Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Bioavailability; Mucoadhesion; Drug; Dosage form; Pharmacology; Tuberculosis; Lipophilicity; Active ingredient; Chemistry; Medicine; Drug carrier; Stereochemistry","score_opus":0.08563882169745975,"score_gpt":0.3943502260694476,"score_spread":0.30871140437198785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197910357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940122,0.0006033314,0.000806854,0.00079028815,0.00056070695,0.00073078077,0.000015497137,0.00008451469,0.0023958313],"genre_scores_gemma":[0.9535578,0.00006907942,0.043567047,0.00029438297,0.00009010452,0.000053025786,0.00023422294,0.000024685369,0.0021096815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99684423,0.00033378837,0.0011915884,0.0005471375,0.0005469243,0.0005363253],"domain_scores_gemma":[0.9981287,0.00024345328,0.0007201942,0.00022213165,0.00040564378,0.00027986034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012199993,0.0003851678,0.00061480294,0.00017319244,0.00029162396,0.000033288914,0.00035017397,0.00023401275,0.00050596124],"category_scores_gemma":[0.00014712967,0.00036949708,0.00015872407,0.0005714566,0.00015966626,0.0003177727,0.00020614908,0.00063994457,0.000030072584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048213394,0.00081086956,0.0046750098,0.0004483471,0.0005506941,0.00007752915,0.009515643,0.000109964334,0.9233449,0.00030733552,0.005528252,0.054149285],"study_design_scores_gemma":[0.0023000923,0.000039259663,0.021056127,0.00015807805,0.00015876097,0.000025704365,0.00053701806,0.0004293712,0.94226295,0.000221075,0.03241589,0.00039569093],"about_ca_topic_score_codex":0.00001719161,"about_ca_topic_score_gemma":0.00012745142,"teacher_disagreement_score":0.053753596,"about_ca_system_score_codex":0.00030550736,"about_ca_system_score_gemma":0.0014899988,"threshold_uncertainty_score":0.9998757},"labels":[],"label_agreement":null},{"id":"W3198549098","doi":"10.33380/2305-2066-2021-10-3-105-113","title":"Determination of Lappaconitin, Diterpene Alkaloide Obtained from Plants <i>Aconitum leucostomum</i>, and its Active Metabolite N-desacetyllappaconitin in Human Plasma and Blood","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Alkaloid; Chemistry; Chromatography; Diterpene; High-performance liquid chromatography; Protein precipitation; Pharmacokinetics; Metabolite; Aconitum; Quantitative analysis (chemistry); Active metabolite; Pharmacology; Stereochemistry; Biochemistry; Medicine","score_opus":0.056250910114366164,"score_gpt":0.3656614644053199,"score_spread":0.3094105542909537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198549098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934673,0.002164664,0.00006296281,0.00046022722,0.00017961996,0.0005806309,0.00030122875,0.000035451438,0.0027479567],"genre_scores_gemma":[0.9947174,0.001326522,0.0010241665,0.0001786233,0.00009136464,0.00009023625,0.0011200518,0.000026064075,0.0014255435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970451,0.0006458759,0.00073427847,0.00059561204,0.00046811134,0.00051104324],"domain_scores_gemma":[0.99812317,0.00078181527,0.00036864867,0.00016432299,0.00028627703,0.00027574573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011375016,0.0003314072,0.0005032005,0.00031941762,0.00026082568,0.000052392916,0.00016880038,0.00030722414,0.00016612545],"category_scores_gemma":[0.00038107153,0.00035950248,0.000039138857,0.0002569258,0.00020138867,0.00033724715,0.00010683009,0.00057521457,0.000014748162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047367057,0.00035290583,0.0023837504,0.00015136845,0.00015356319,0.00039182778,0.003030431,0.000008314119,0.95946705,0.0009759215,0.00010952052,0.03250165],"study_design_scores_gemma":[0.004954345,0.000082972125,0.029590603,0.00022841425,0.00017360375,0.00008839108,0.00058873085,0.0013539294,0.9498736,0.00031322415,0.01237495,0.00037721256],"about_ca_topic_score_codex":0.000035271827,"about_ca_topic_score_gemma":0.0012508297,"teacher_disagreement_score":0.032124437,"about_ca_system_score_codex":0.00013540946,"about_ca_system_score_gemma":0.0006614073,"threshold_uncertainty_score":0.9998857},"labels":[],"label_agreement":null},{"id":"W3217107789","doi":"10.33380/2305-2066-2020-9-2-133-139","title":"Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Valganciclovir; Ganciclovir; Prodrug; Active metabolite; Protein precipitation; High-performance liquid chromatography; Pharmacokinetics; Metabolite; Chromatography; Human cytomegalovirus; Chemistry; Pharmacology; Biology; Biochemistry","score_opus":0.04124204494144324,"score_gpt":0.3327477137431953,"score_spread":0.29150566880175205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217107789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960463,0.00033665018,0.0014287154,0.0006758525,0.000019602849,0.0007556801,0.000009958204,0.000032255135,0.00069495296],"genre_scores_gemma":[0.9738905,0.00010957757,0.02506907,0.000117275675,0.00003504501,0.000073828785,0.00025086213,0.00002366296,0.00043021145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797344,0.00010726848,0.0006629315,0.0004632937,0.000541234,0.00025183285],"domain_scores_gemma":[0.99922377,0.000054667104,0.00024589585,0.00010578768,0.00017320974,0.00019668129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007564061,0.000217958,0.00039589914,0.00021470932,0.0001320279,0.000048564594,0.00006181614,0.00011106075,0.000028245959],"category_scores_gemma":[0.00014484843,0.0002166253,0.000026826667,0.00035857997,0.000043953147,0.00033356503,0.0000621584,0.00021886983,0.0000068239533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044937426,0.00021949681,0.0046312395,0.00068973633,0.00007994968,0.000023605067,0.022540137,0.000006654451,0.76816887,0.00087797194,0.0002745645,0.20203838],"study_design_scores_gemma":[0.0017298595,0.000054823595,0.048177704,0.000085066626,0.000030202656,0.000012501004,0.0005106178,0.0017052548,0.9308918,0.000029022864,0.01654695,0.00022620859],"about_ca_topic_score_codex":0.000038341368,"about_ca_topic_score_gemma":0.00006585618,"teacher_disagreement_score":0.20181216,"about_ca_system_score_codex":0.00016488155,"about_ca_system_score_gemma":0.00035527867,"threshold_uncertainty_score":0.8833723},"labels":[],"label_agreement":null},{"id":"W3217188055","doi":"10.33380/2305-2066-2021-10-4-177-189","title":"Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Candesartan; Hydrochlorothiazide; Chromatography; Chemistry; Valsartan; High-performance liquid chromatography; Indapamide; Formic acid; Angiotensin II; Pharmacology; Diuretic; Medicine; Internal medicine; Blood pressure","score_opus":0.021959117761044037,"score_gpt":0.32421242551069546,"score_spread":0.3022533077496514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217188055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762216,0.00012434392,0.0037283427,0.00021676705,0.00003574221,0.00010445388,0.000008514871,0.000037653524,0.019522531],"genre_scores_gemma":[0.9684058,0.00003525526,0.025746819,0.00005135842,0.000029225066,0.000020803178,0.00011336693,0.000017447202,0.005579918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984057,0.00006553327,0.0006165242,0.000363729,0.00033041422,0.00021809683],"domain_scores_gemma":[0.9991024,0.0003222133,0.00018936527,0.0001870644,0.000103235245,0.00009571684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003924664,0.00017045633,0.0002507827,0.00005290141,0.00008193013,0.000041151816,0.00010601533,0.00012482636,0.00028067545],"category_scores_gemma":[0.00057712203,0.00018907156,0.000028745571,0.00015467251,0.0001024145,0.00010658983,0.00004813869,0.00019566542,0.0000037390494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051121584,0.00026567004,0.005970843,0.0004746409,0.000032370168,0.00013272016,0.0015444771,0.00005317583,0.91603315,0.0014082369,0.00034021953,0.073693365],"study_design_scores_gemma":[0.000617312,0.0000071363165,0.00026864986,0.00012720899,0.000022691012,0.000020238158,0.00016717319,0.011624349,0.9777044,0.0009192504,0.0082822675,0.00023930584],"about_ca_topic_score_codex":0.000038133672,"about_ca_topic_score_gemma":0.0003348106,"teacher_disagreement_score":0.07345406,"about_ca_system_score_codex":0.0001734708,"about_ca_system_score_gemma":0.00015435279,"threshold_uncertainty_score":0.7710115},"labels":[],"label_agreement":null},{"id":"W4213452411","doi":"10.33380/2305-2066-2022-11-1-140-147","title":"Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC \"Pharmcenter VILAR\", Russia)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Cmax; Pharmacology; Drug; Plasma concentration; Alkaloid; Chemistry; Medicine; Stereochemistry","score_opus":0.08764112469374505,"score_gpt":0.4045696862444642,"score_spread":0.31692856155071913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213452411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330574,0.00020777709,0.00005307079,0.0009875521,0.000874372,0.0014660417,0.00006376001,0.000041374326,0.0030003006],"genre_scores_gemma":[0.9969704,0.00006935423,0.00010007135,0.00034414313,0.00011044485,0.00016679625,0.00011025862,0.000026711663,0.0021018232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99591357,0.0010848674,0.00096542353,0.00040157273,0.0011498835,0.00048468568],"domain_scores_gemma":[0.9982269,0.00034659554,0.00076503056,0.000325381,0.00018603336,0.00015005219],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029076939,0.00026844424,0.0003837372,0.00020406787,0.0005858994,0.00001507959,0.0005965276,0.000064166365,0.0010159886],"category_scores_gemma":[0.00013671436,0.00023426826,0.00009390915,0.0005197587,0.00019048722,0.00011487623,0.00033380164,0.0012481912,0.00001065005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00467986,0.009677325,0.36699468,0.001099335,0.0014841269,0.00061170117,0.03281892,0.0148282,0.51136464,0.00033642736,0.023204518,0.032900237],"study_design_scores_gemma":[0.009409283,0.00040074636,0.042250108,0.00014182104,0.000455396,0.00014684944,0.0062511293,0.0051189,0.8326997,0.000035867328,0.102443494,0.0006466625],"about_ca_topic_score_codex":0.000114543516,"about_ca_topic_score_gemma":0.0002021121,"teacher_disagreement_score":0.32474458,"about_ca_system_score_codex":0.0002503183,"about_ca_system_score_gemma":0.00072505797,"threshold_uncertainty_score":0.99989724},"labels":[],"label_agreement":null},{"id":"W4281633450","doi":"10.33380/2305-2066-2022-11-2-180-186","title":"Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Antibody; Medicine; Virology; Immunoglobulin G; Drug; Polyclonal antibodies; Antiviral drug; Coronavirus disease 2019 (COVID-19); Immunology; Pharmacology; Infectious disease (medical specialty); Disease; Internal medicine","score_opus":0.07213643085207633,"score_gpt":0.3924006549297945,"score_spread":0.32026422407771815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281633450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933181,0.00057404087,0.00034344624,0.0010340868,0.0002893082,0.0021996116,0.00003311984,0.00016295846,0.0020453355],"genre_scores_gemma":[0.9856507,0.000020475192,0.00044835306,0.012183822,0.00015832606,0.0004509426,0.00036692142,0.000052783696,0.00066765037],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952733,0.0003630295,0.0012157481,0.00077242055,0.0018621985,0.0005133359],"domain_scores_gemma":[0.9982398,0.00011217825,0.00047398428,0.00072592514,0.00025387012,0.00019423194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018482009,0.000376723,0.0005322524,0.00048792126,0.00093810004,0.00007584993,0.0005338836,0.000060396527,0.00022647296],"category_scores_gemma":[0.00015254815,0.00039668076,0.00012854833,0.00097239215,0.00015051548,0.00013455856,0.00029021167,0.0006004108,0.000036865826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061105597,0.037698604,0.045058295,0.0012787507,0.0008860431,0.0021331585,0.08169386,0.0005561958,0.7039258,0.00056560483,0.08619975,0.03389337],"study_design_scores_gemma":[0.020783242,0.0009567116,0.0015791873,0.00003446008,0.000093577815,0.00004655523,0.013856664,0.00021145932,0.08542112,0.00006691956,0.87642306,0.0005270632],"about_ca_topic_score_codex":0.00025533204,"about_ca_topic_score_gemma":0.0001607357,"teacher_disagreement_score":0.7902233,"about_ca_system_score_codex":0.0013818858,"about_ca_system_score_gemma":0.0023248566,"threshold_uncertainty_score":0.9998485},"labels":[],"label_agreement":null},{"id":"W4294681241","doi":"10.33380/2305-2066-2022-11-3-220-229","title":"Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Favipiravir; Chromatography; High-performance liquid chromatography; Chemistry; Pharmacokinetics; Protein precipitation; Therapeutic drug monitoring; Formic acid; Pharmacology; Medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.03748672329783132,"score_gpt":0.33831060084608994,"score_spread":0.3008238775482586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294681241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96128094,0.000034447974,0.037220865,0.00034844925,0.00006173116,0.000743818,0.0000034312977,0.000008187883,0.00029813743],"genre_scores_gemma":[0.9066033,0.000008649409,0.09263773,0.000030064179,0.000014027655,0.00005348868,0.00015881291,0.000009452736,0.0004844683],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891216,0.00004214961,0.0005013932,0.00016083666,0.0002832107,0.00010024055],"domain_scores_gemma":[0.9994271,0.00008840289,0.0002736039,0.00009987688,0.0000871507,0.0000238862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010018413,0.00008897037,0.00016110469,0.00012805808,0.00015878835,0.000008615715,0.000057907047,0.000024553388,0.000016009913],"category_scores_gemma":[0.000036411628,0.000077204364,0.000024564713,0.00014985836,0.0000294174,0.000038129616,0.000043453092,0.0000828232,2.0354071e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006455406,0.0010579505,0.013386421,0.0011226349,0.0001291181,0.000011118195,0.029380273,0.0012726758,0.4204712,0.011486446,0.0006270523,0.5204096],"study_design_scores_gemma":[0.0024601622,0.00012347085,0.07199369,0.000071770985,0.000076527715,0.00001910386,0.0013729394,0.014702858,0.8827304,0.00014949635,0.026122956,0.00017661716],"about_ca_topic_score_codex":0.0000157546,"about_ca_topic_score_gemma":0.000019816907,"teacher_disagreement_score":0.520233,"about_ca_system_score_codex":0.00008557338,"about_ca_system_score_gemma":0.0001806883,"threshold_uncertainty_score":0.31483027},"labels":[],"label_agreement":null},{"id":"W4313415459","doi":"10.33380/2305-2066-2022-11-4(1)-120-127","title":"Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Trastuzumab; Antibody; Medicine; Monoclonal antibody; Immunogenicity; Pharmacology; Internal medicine; Immunology; Cancer; Breast cancer","score_opus":0.037261346888283316,"score_gpt":0.34628905501674784,"score_spread":0.30902770812846453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313415459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962277,0.00007969726,0.0011053331,0.0011405139,0.000077923345,0.000829962,0.000010871196,0.000012961341,0.00051503297],"genre_scores_gemma":[0.9595984,0.000012639676,0.03749703,0.000067688314,0.000025905307,0.00017149093,0.00020934072,0.000011511292,0.002405977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984427,0.0001051665,0.0004889299,0.00024908938,0.0005237964,0.00019028822],"domain_scores_gemma":[0.99947447,0.00006668143,0.00019300719,0.00012399736,0.00010402679,0.000037838745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010619,0.00012741631,0.00021247579,0.00016231059,0.00046780804,0.000020893884,0.000105424915,0.000032465632,0.000031415737],"category_scores_gemma":[0.000047515492,0.00010248406,0.000042273477,0.00021709986,0.000049719198,0.00008732862,0.00011226884,0.00014306184,5.6273996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062359695,0.001060073,0.35609615,0.0020600585,0.00017209697,0.000023402703,0.034586884,0.0003512247,0.33203208,0.006873889,0.0014941941,0.26462635],"study_design_scores_gemma":[0.0010520243,0.00006842252,0.50318044,0.000101959355,0.000020755084,0.00003291329,0.0012989141,0.0008246637,0.461054,0.00020854356,0.031982493,0.00017487118],"about_ca_topic_score_codex":0.000051282386,"about_ca_topic_score_gemma":0.00011865949,"teacher_disagreement_score":0.26445147,"about_ca_system_score_codex":0.00019490506,"about_ca_system_score_gemma":0.00036736194,"threshold_uncertainty_score":0.41791785},"labels":[],"label_agreement":null},{"id":"W4322752875","doi":"10.33380/2305-2066-2023-12-1-215-226","title":"Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Favipiravir; Chromatography; Chemistry; High-performance liquid chromatography; Formic acid; Ammonium formate; Electrospray ionization; Tandem mass spectrometry; Selected reaction monitoring; Triethylamine; Mass spectrometry; Medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.014596228474675564,"score_gpt":0.28706257507463406,"score_spread":0.2724663465999585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322752875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966719,0.000105478706,0.00045535926,0.00040533536,0.000081801525,0.00053596345,0.000015666188,0.00007496979,0.0016535082],"genre_scores_gemma":[0.99176896,0.00015795618,0.0022137023,0.00006487008,0.000051270414,0.000012767756,0.00069218216,0.000030017474,0.005008251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828595,0.000040126222,0.0006462005,0.00035963807,0.00039086863,0.00027721448],"domain_scores_gemma":[0.99930567,0.00007600634,0.0002236413,0.00018101066,0.00010360856,0.000110072746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004267386,0.00021705685,0.00033226766,0.00028999755,0.00009801152,0.00003372516,0.000088416986,0.00010028931,0.00002214065],"category_scores_gemma":[0.0000894702,0.0002151334,0.000040906318,0.00042511694,0.00008199028,0.000097214,0.000046507703,0.00016113798,0.000018640081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023608672,0.000561495,0.01631478,0.0006653262,0.00008124151,0.00021958533,0.0040559536,0.00025918314,0.90319103,0.0010038248,0.002349121,0.07106235],"study_design_scores_gemma":[0.007252865,0.0002571467,0.13148403,0.00044064462,0.00021020744,0.000060360955,0.0003847155,0.06363883,0.74871665,0.0002865562,0.046414476,0.0008535063],"about_ca_topic_score_codex":0.00008298138,"about_ca_topic_score_gemma":0.000057131158,"teacher_disagreement_score":0.15447439,"about_ca_system_score_codex":0.00007599718,"about_ca_system_score_gemma":0.000102678634,"threshold_uncertainty_score":0.8772886},"labels":[],"label_agreement":null},{"id":"W4379276081","doi":"10.33380/2305-2066-2023-12-2-146-153","title":"Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC \"PROMOMED RUS\", Russia)","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Pharmacology; Drug; Medicine; Favipiravir; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease","score_opus":0.1664712180694004,"score_gpt":0.44900681623139765,"score_spread":0.28253559816199725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106133,0.00005107683,0.00060102355,0.0011904936,0.0017468715,0.0037469133,0.000068958805,0.00036982857,0.0011635158],"genre_scores_gemma":[0.9936178,0.00012243501,0.00053133204,0.0004641642,0.00022520352,0.0010690541,0.000563105,0.000052154417,0.0033547883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966987,0.00046524612,0.001096107,0.0006510561,0.00051985035,0.00056906533],"domain_scores_gemma":[0.9983316,0.00026460143,0.0006107707,0.0003385552,0.0002505667,0.00020391397],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026412138,0.00039460332,0.00044180927,0.00043687076,0.000721536,0.000052153984,0.0003538601,0.000250034,0.00017910053],"category_scores_gemma":[0.00013176432,0.0004143557,0.00011649429,0.0009131405,0.000102903694,0.0002841548,0.00011270923,0.0006237597,0.00013098789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026720625,0.010898043,0.0058629946,0.0007411478,0.00056551176,0.00006437825,0.047004383,0.0014593119,0.5865972,0.0004917363,0.052025974,0.29161724],"study_design_scores_gemma":[0.015747,0.0007581603,0.0045766756,0.00008260416,0.00025054585,0.000009855941,0.0033443004,0.009417614,0.57812536,0.00039106756,0.38647202,0.00082477153],"about_ca_topic_score_codex":0.000053545526,"about_ca_topic_score_gemma":0.00018242723,"teacher_disagreement_score":0.33444607,"about_ca_system_score_codex":0.00017688755,"about_ca_system_score_gemma":0.00029915734,"threshold_uncertainty_score":0.99983084},"labels":[],"label_agreement":null},{"id":"W4379276111","doi":"10.33380/2305-2066-2023-12-2-135-145","title":"Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Ritonavir; Chromatography; Chemistry; Protein precipitation; Formic acid; Electrospray ionization; High-performance liquid chromatography; Tandem mass spectrometry; Mass spectrometry; Medicine; Viral load; Virology; Virus","score_opus":0.024230403010418983,"score_gpt":0.32547930253418916,"score_spread":0.3012488995237702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662024,0.000052711173,0.00008239095,0.00027922637,0.00004216424,0.00041171507,0.000004341309,0.00007114716,0.0024360942],"genre_scores_gemma":[0.9978797,0.000011014512,0.0005950663,0.00043473975,0.00003205071,0.0000519029,0.0001208663,0.00001696159,0.00085773267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998576,0.000041748717,0.00042456065,0.0002725651,0.0004611868,0.00022393934],"domain_scores_gemma":[0.99948853,0.00012428434,0.00011162027,0.00015399826,0.00009028669,0.000031251468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043590384,0.0001340952,0.00020299738,0.00027222402,0.000085487074,0.00002965162,0.00007947577,0.00009266361,0.0000049937644],"category_scores_gemma":[0.00014709106,0.00013319642,0.000024726187,0.0003976032,0.00007370061,0.000118636,0.000037563277,0.00014582573,0.000025765154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032348165,0.000426634,0.09082135,0.0008695522,0.00003626709,0.00035359163,0.00677576,0.000008857664,0.7333822,0.00027170742,0.0035151883,0.1632154],"study_design_scores_gemma":[0.0032204369,0.0002001156,0.04533557,0.00036464783,0.000022833869,0.00004667903,0.00062855275,0.011813051,0.83753717,0.00026540767,0.10018036,0.00038518073],"about_ca_topic_score_codex":0.00019131176,"about_ca_topic_score_gemma":0.0004428991,"teacher_disagreement_score":0.16283022,"about_ca_system_score_codex":0.00014330226,"about_ca_system_score_gemma":0.00020781334,"threshold_uncertainty_score":0.54315925},"labels":[],"label_agreement":null},{"id":"W4379276540","doi":"10.33380/2305-2066-2023-12-2-62-72","title":"Development, Validation and Approbation Analytical Method for the Quantitative Determination of Taurine by HPLC-UV Method in the Test of Comparative Dissolution Kinetics","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Taurine; Chromatography; Chemistry; Dissolution; Derivatization; Kinetics; High-performance liquid chromatography; Dosage form; Amino acid; Biochemistry; Organic chemistry","score_opus":0.04815994886209583,"score_gpt":0.372205494514972,"score_spread":0.32404554565287613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276540","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30493772,0.00009825017,0.693574,0.00046935602,0.00002213661,0.00074400177,0.000033289565,0.0000066138887,0.00011462755],"genre_scores_gemma":[0.7145374,0.000068156776,0.28328276,0.000021078778,0.00002482832,0.00032359592,0.0014456339,0.0000080393875,0.00028853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998909,0.00012556535,0.00044966242,0.0002198974,0.00017875206,0.000117120144],"domain_scores_gemma":[0.99900824,0.00037041245,0.00030102758,0.00015234266,0.00015041734,0.00001753475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012573529,0.000113013775,0.00014551621,0.000073871306,0.00010479212,0.000018967745,0.00011464445,0.00005604426,7.7212195e-7],"category_scores_gemma":[0.0002462872,0.000082018974,0.000026953578,0.00034118813,0.0000684146,0.000014352337,0.000031572283,0.000045322267,5.893259e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008788237,0.00030747024,0.0010451485,0.0001240194,0.000048294965,1.1039315e-7,0.0063620056,0.00036120685,0.92003167,0.008730438,0.0017128234,0.061188944],"study_design_scores_gemma":[0.00061060034,0.00008567211,0.049195785,0.000023317943,0.000054983386,0.0000025961062,0.0020004546,0.039837014,0.89024824,0.00053360756,0.017232062,0.0001756849],"about_ca_topic_score_codex":0.000013606394,"about_ca_topic_score_gemma":0.00009628888,"teacher_disagreement_score":0.41029125,"about_ca_system_score_codex":0.000015749916,"about_ca_system_score_gemma":0.00007971003,"threshold_uncertainty_score":0.33446366},"labels":[],"label_agreement":null},{"id":"W4379276580","doi":"10.33380/2305-2066-2023-12-2-190-197","title":"Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Trastuzumab; Medicine; Immunogenicity; Antibody; Bioequivalence; Gold standard (test); Pharmacology; Cancer; Immunology; Internal medicine; Breast cancer; Pharmacokinetics","score_opus":0.04488240243248364,"score_gpt":0.34684753827839326,"score_spread":0.3019651358459096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731946,0.000055618384,0.0006473614,0.0008190339,0.00008861841,0.0007497754,0.0000050703334,0.000040704865,0.00027433984],"genre_scores_gemma":[0.98497707,0.000053717707,0.013063985,0.000032893055,0.000047332935,0.00008414968,0.00012846515,0.00001541053,0.0015970009],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847126,0.0000691182,0.0005227587,0.0002823408,0.00039068857,0.0002638339],"domain_scores_gemma":[0.9994636,0.00007581992,0.00016102378,0.00013082803,0.0001178401,0.0000508973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000987376,0.00015383994,0.0002426178,0.00022649489,0.00031336746,0.000032348235,0.00008392449,0.00006818409,0.0000057542065],"category_scores_gemma":[0.00006182096,0.00011820119,0.000051367773,0.00041537723,0.000056541274,0.000108997105,0.000060602983,0.00013027863,0.000002454288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001716794,0.00024216675,0.113346614,0.001464601,0.00016399704,0.000012635684,0.009779014,0.00011304615,0.8069083,0.0013765474,0.00025602354,0.06616535],"study_design_scores_gemma":[0.0005838187,0.000026431235,0.3689494,0.00015781545,0.00002112224,0.000012330679,0.0004394527,0.00023800193,0.625495,0.000086042994,0.0038933572,0.00009721957],"about_ca_topic_score_codex":0.00008769129,"about_ca_topic_score_gemma":0.00039043356,"teacher_disagreement_score":0.2556028,"about_ca_system_score_codex":0.00007266601,"about_ca_system_score_gemma":0.00022676481,"threshold_uncertainty_score":0.48201048},"labels":[],"label_agreement":null},{"id":"W4388760934","doi":"10.33380/2305-2066-2023-12-4-1467","title":"Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Granulation; Anhydrous; Citric acid; Compaction; Raw material; Pulp and paper industry; Materials science; Chemical engineering; Chemistry; Food science; Composite material; Engineering; Organic chemistry","score_opus":0.1266812609583558,"score_gpt":0.41182161228398584,"score_spread":0.28514035132563004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388760934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985284,0.00028265174,0.0020676493,0.005406735,0.0021618553,0.0012796832,0.00005732642,0.00038882525,0.0030713053],"genre_scores_gemma":[0.9900406,0.00009380063,0.0005066186,0.0002573138,0.000120434954,0.0002696465,0.00020890668,0.000017289909,0.008485417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985388,0.00012845703,0.00055066595,0.00026926745,0.0001624617,0.00035038337],"domain_scores_gemma":[0.9989592,0.0003714187,0.00026287083,0.0002315607,0.0001220178,0.000052953885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015540606,0.0001663555,0.00022042537,0.00018555796,0.00042951078,0.000026227195,0.0002954662,0.00022987614,0.0001384019],"category_scores_gemma":[0.0001239501,0.00013761334,0.000058945985,0.00035258275,0.00014412879,0.00011561016,0.00006443186,0.00024094092,0.00011829098],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014239278,0.0005785798,0.007882563,0.0018509808,0.001157334,0.00006755109,0.016423648,0.008795005,0.21422634,0.0110593205,0.60606503,0.13046974],"study_design_scores_gemma":[0.00070307974,0.000024106661,0.0028094,0.000037159236,0.000046053527,0.000008710922,0.0010132233,0.007897055,0.40553892,0.00043056931,0.581308,0.00018373587],"about_ca_topic_score_codex":0.000030636475,"about_ca_topic_score_gemma":0.00009411359,"teacher_disagreement_score":0.1913126,"about_ca_system_score_codex":0.000064790176,"about_ca_system_score_gemma":0.00015140565,"threshold_uncertainty_score":0.56117094},"labels":[],"label_agreement":null}]}